India’s clinical research industry comes to a standstill
With just five global clinical trials approved this year, India's once booming clinical research industry has stagnated in 2013
With just five global clinical trials approved this year, India’s once booming clinical research industry, pegged at $450 million in 2010–11 by market research firm Frost and Sullivan, has completely stagnated in 2013. The industry was expected to grow at 12% a year and pass the $1 billion mark in 2016.
A Supreme Court ruling on 3 January revoked the Indian drugs regulator’s powers to approve clinical trials, making the health ministry responsible for the approval process. The trials have yet again been put on hold until 16 December after the apex court expressed concern over the approvals given by the health ministry.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!